In the rapidly evolving world of cancer treatments, CAR-T cell therapy stands out for its effectiveness tackling hematologic tumors. Booming demand for such therapies powered Legend Biotech Corp. LEGN ...
Why Genscript Biotech is on investors’ radar Genscript Biotech (SEHK:1548) has drawn fresh attention after recent share price swings, with the stock showing a 1 day gain of 1.38%, but a weaker past 3 ...
Good day, and thank you for standing by. Welcome to GenScript Biotech Annual Results Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now ...
R&D Innovation to Lead the Future, Deepening Customer Value Creation From the performance during the 2023 reporting period, GenScript Group's overall development is optimistic, with each business ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results